From the latest ADA position statements to special issues to dietary intake, here’s the latest info to share with your patients about diabetic eye disease.
Diabetic Eye Awareness
About 33% of patients with diabetes have diabetic retinopathy (DR), and, of those, 7% will progress to diabetic macular edema (DME).1 Patients with DR and/or DME incur significant medical costs.
About 33% of patients with diabetes have some level of diabetic retinopathy (DR), and, of those, 7% will progress to diabetic macular edema (DME).1 Medical therapies have decreased the severity of DME and DR in recent years, an
Although a number of medical treatment advances for diabetic retinopathy (DR) and diabetic macular edema (DME) have occurred in recent years—predominantly through the introduction of the anti-vascular endothelial growth factor (VEGF) agen
This year’s Retina Subspecialty Day at the American Academy of Ophthalmology meeting included a session devoted to diabetes—most of which highlighted study data from the Diabetic Retinopathy Clinical Research Network (DRCR.net).
November has been declared by Prevent Blindness as Diabetic Eye Disease Awareness Month to educate the public on the effects of diabetes on vision, risk factors and treatment options.
The Centers for Disease Control estimates that more than 84 million U.S. adults, or 40% of the U.S. adult population, is prediabetic.
A better understanding of the pathophysiologic mechanisms of diabetes has resulted in improved control of its local and systemic comorbidities. Further developments are needed, however, considering the growing number of diabetic patients and who are at risk for late-stage diabetic eye disease.